Reims, France

Craig Steven Harris

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 7.4

ph-index = 2

Forward Citations = 5(Granted Patents)


Location History:

  • Reims, FR (2009 - 2011)
  • Cheshire, GB (2015)
  • Macclesfield, GB (2017)

Company Filing History:


Years Active: 2009-2017

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Craig Steven Harris

Introduction

Craig Steven Harris is an accomplished inventor based in Reims, France. With a total of four patents to his name, Harris has made significant contributions to the field of chemical compounds, particularly in the development of pharmaceutical compositions. His work has garnered attention for its potential applications in treating various cell proliferative disorders.

Latest Patents

Harris's latest patents involve the invention of chemical compounds characterized by a specific formula. These compounds, or their pharmaceutically acceptable salts, have distinct properties that can be further defined within the scope of his research. The processes for their preparation and the pharmaceutical compositions that incorporate these compounds are designed for use in the treatment of cell proliferative disorders, showcasing Harris's dedication to advancing medical science.

Career Highlights

Currently, Craig Steven Harris works at AstraZeneca AB, a leading global pharmaceutical company. His role within the organization allows him to participate in groundbreaking research and development initiatives aimed at improving healthcare outcomes. His interdisciplinary approach and focus on innovation contribute to the company's mission to deliver life-changing medicines.

Collaborations

Harris's innovative efforts are often complemented by the talents of his coworkers, including Benedicte Delouvrie and Gilles Ouvry. Their collaborative work enhances the potential for impactful discoveries, as they bring together diverse expertise to tackle complex challenges in the pharmaceutical field.

Conclusion

In conclusion, Craig Steven Harris stands out as a notable inventor whose work at AstraZeneca AB is paving the way for advancements in the treatment of cell proliferative disorders. With four patents to his credit, his contributions to the realm of chemical compounds are significant, reflecting his commitment to innovation and collaborative research in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…